| 165.75 Data as of Jun 13 |  0.00 / 0.00%Today’s Change | 140.00 Today|||52-Week Range 193.70 | +1.84% Year-to-Date |
| J&J to Buy Aragon for $1 Billion - Analyst Blog 11:20am / Zacks.com | Lilly Alzheimer's Study Terminated - Analyst Blog Jun 14 / Zacks.com |
| Why MannKind Is Poised to Pull Back 9:51am / MotleyFool.com | Sanofi's Fluzone Quadrivalent Gets FDA Nod - Analyst Blog Jun 13 / Zacks.com |
| Benzinga's Top Pre-Market Losers Jun 17 / Benzinga | CHMP Positive on Sanofi's Lantus - Analyst Blog Jun 11 / Zacks.com |
| 1 Thing You Always Wanted to Know About Drugs (but Were Afraid to Ask) Jun 14 / MotleyFool.com | Novo Nordisk A/S (NVO): Today's Featured Drugs Winner Jun 11 / TheStreet.com |
| Encouraging Data on Novartis' Gilenya - Analyst Blog Jun 14 / Zacks.com | Tme to Buy This Defensive Growth Stock? Jun 11 / MotleyFool.com |
| Previous close | 165.75 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 0 |
| Average volume (3 months) | 1,673 |
| Market cap | $73.3B |
| Dividend yield | 1.88% |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | -- |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
.
